4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and vorinostat

4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide has been researched along with vorinostat in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Atadja, P; Bair, KW; Cornell, WD; Green, MA; Howell, KL; Jung, M; Kwon, P; Remiszewski, SW; Sambucetti, LC; Trogani, N; Walker, H1
Belvedere, S; Miller, TA; Witter, DJ1
Cheng, F; Dong, N; Huang, J; Jiang, X; Li, J; Lin, P; Liu, M; Lu, W; Ouyang, P; Tang, Y; Wu, D; Wu, Z; Xu, Z; Yao, X; Zeng, M; Zhang, C; Zou, S1
Ballante, F; Marshall, GR; Reddy, DR; Zhou, NJ1
Brindisi, M; Brogi, S; Butini, S; Campiani, G; Gemma, S; Saraswati, AP1
Chiba, DE; Dos Santos, JL; Lopes, JR1

Reviews

2 review(s) available for 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and vorinostat

ArticleYear
Histone deacetylase inhibitors.
    Journal of medicinal chemistry, 2003, Nov-20, Volume: 46, Issue:24

    Topics: Animals; Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Models, Molecular; Sequence Alignment; Structure-Activity Relationship

2003
HIV latency reversal agents: A potential path for functional cure?
    European journal of medicinal chemistry, 2021, Mar-05, Volume: 213

    Topics: Anti-HIV Agents; CD4-Positive T-Lymphocytes; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Molecular Structure; Virus Latency

2021

Other Studies

4 other study(ies) available for 4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide and vorinostat

ArticleYear
Inhibitors of human histone deacetylase: synthesis and enzyme and cellular activity of straight chain hydroxamates.
    Journal of medicinal chemistry, 2002, Feb-14, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Benzamides; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Hydroxylamines; Models, Molecular; Promoter Regions, Genetic; Structure-Activity Relationship; Tumor Cells, Cultured

2002
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4 Biosynthesis.
    Journal of medicinal chemistry, 2017, 03-09, Volume: 60, Issue:5

    Topics: Acute Lung Injury; Animals; Epoxide Hydrolases; Female; Histone Deacetylase Inhibitors; Idiopathic Pulmonary Fibrosis; Leukotriene B4; Mice; Mice, Inbred C57BL; Neutrophils

2017
Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy.
    Bioorganic & medicinal chemistry, 2017, 04-01, Volume: 25, Issue:7

    Topics: Animals; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; In Vitro Techniques; Molecular Docking Simulation; Molecular Structure; Quantitative Structure-Activity Relationship; Schistosoma mansoni

2017
Old but Gold: Tracking the New Guise of Histone Deacetylase 6 (HDAC6) Enzyme as a Biomarker and Therapeutic Target in Rare Diseases.
    Journal of medicinal chemistry, 2020, 01-09, Volume: 63, Issue:1

    Topics: Animals; Biomarkers; Cell Line; Epigenesis, Genetic; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Humans; Mice; Protein Processing, Post-Translational; Rare Diseases

2020